Tag: Diabetes: Type II
Ranolazine Added to Glimepiride Cuts HbA1c in T2DM
Association not seen for patients treated with background metformin therapy
Low Resilience to Stress in Teens May Up Later T2DM Risk
Further research needed to discover underlying cause for increase in risk
Reduction in Proximal, Distal Leg Muscle Strength in T2DM
Proximal but not distal reduction seen in muscle volume in patients with type 2 diabetes
Eating Potatoes on a Regular Basis May Up Risk of T2DM
Risk up for every three servings/week of baked, boiled, mashed potatoes, and especially fries
Intra-Pancreatic Triacylglycerol Drops With Weight Loss in T2DM
Decrease seen after gastric bypass for patients with type 2 diabetes, not with normal glucose tolerance
Meta-Analysis: Risk of Dementia Up in Type 2 Diabetes
Greater additional risk for women with diabetes for vascular, but not nonvascular, dementia
Excessive Testing May Be Compromising T2DM Care
In U.S. cohort, more than 60 percent received too many HbA1c tests
Review Compares Outcomes, Safety for Once-Weekly GLP-1RAs
Greater reduction of HbA1c, fasting plasma glucose, body weight for dulaglutide, exenatide, taspoglutide
Breaking Up Prolonged Sitting Benefits Postmenopausal Women
Reductions in postprandial glucose, insulin, NEFA responses for overweight/obese women
Testosterone Treatment Tied to Improved Insulin Sensitivity
Increased insulin sensitivity in men with type 2 diabetes and hypogonadotropic hypogonadism